
Sign up to save your podcasts
Or
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
5
77 ratings
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
1,043 Listeners
31 Listeners
275 Listeners
309 Listeners
340 Listeners
386 Listeners
121 Listeners
318 Listeners
195 Listeners
84 Listeners
88 Listeners
425 Listeners
144 Listeners
18 Listeners
70 Listeners